Electrophoretic mobility shift assay (EMSA), also known as gel retardation assay, is an important experimental method for studying the interaction of nucleic acids and proteins, and is the core technology for qualitative and quantitative analysis of interaction systems. This technology is often used to verify the interaction between transcription factors and promoters, and is now further developed to study DNA-protein interactions, RNA-protein interactions, and even DNA-RNA interactions.
EMSA is based on the principle that the mobility of nucleic acid-protein complexes is significantly reduced in native-PAGE, resulting in a lagged band in the final detection. In this experiment, specific and non-specific probes need to be designed so that they can bind to the target protein after incubation. As the molecular mass of the probe-protein complex increases, the immigration rates of the complex will reduce in SDS-PAGE compared with the probe that is not bound to the protein. Because there are some special markers in the probe (such as 32P), it can show bands by transmembrane, coloration or exposure to the probe-protein complex to prove the interaction between nucleic acid and protein. The experiment can also evaluate the binding affinity and even calculate the association and dissociation constant.
Figure 1. The schematic illustration of electrophoretic mobility shift assays (EMSA) (Song, C.C.; et al. 2015)
Creative Proteomics has accumulated nearly two decades of EMSA experience. Under the management of our professional technicians, a mature and high-quality EMSA platform has been established, which can help customers comprehensively and systematically analyze nucleotide-protein interactions. We provide a variety of radioactive isotopes and other labeling agents (such as biotin and FAM) to label nucleotides. Unlabeled nucleotides are used as specific competitors to eliminate non-specific nucleotide-protein interactions. In addition, our experts can customize experiments according to different project requirements, including but not limited to making changes in the following aspects:
Used to verify if the probe contains binding sites for the protein. Mutate the binding site, use the mutated probe as a control, and if wild-type probe shows a migration band while the mutated probe does not, it indicates the probe contains binding sites for the protein.
The probe sequence remains unchanged, and the probe without modifying groups is called a cold probe. The cold probe competitively binds to the protein with the labeled probe. The cold probe does not reveal migration bands. Using the cold probe as a control, if the labeled probe shows migration bands and the cold probe migration bands weaken or disappear, false positives are eliminated, increasing experimental accuracy.
Utilizes specific antibodies against the target protein. The protein-probe complex is recognized and bound by the antibody, causing a further increase in migration rate, resulting in a super-shift band above the protein-probe complex. This confirms the specific binding of the probe to the target protein.
Customers can choose different technology platforms according to project requirements, or contact us directly for consultation, and our expert team will provide you with customized experimental procedures.
EMSA is a widely used experimental technique for studying the interactions between proteins and nucleic acids (DNA or RNA). It finds broad applications in various research areas, including but not limited to the following:
Transcription Factor Studies: EMSA is employed to investigate the binding of transcription factors to DNA. Analyzing the binding capacity of transcription factors to specific gene promoters or regulatory elements reveals insights into gene regulatory networks and transcriptional control mechanisms.
RNA-Binding Protein Research: EMSA is used to study the interaction between RNA-binding proteins (RBPs) and RNA. Exploring the binding of RBPs to target RNA sequences provides understanding of RBPs' functions in processes such as post-transcriptional regulation, RNA stability, and translation control.
DNA Repair and Damage Recognition: EMSA is applied to study the binding of DNA repair enzymes and damage recognition proteins to DNA damage sites. Analyzing these interactions contributes to a deeper understanding of DNA repair mechanisms and DNA damage response pathways.
Drug Screening and Target Research: EMSA is utilized for screening and assessing the binding ability of potential drug molecules to specific DNA or RNA sequences. By detecting the interaction between drugs and targets, it evaluates drug affinity and selectivity, providing crucial information for drug development and targeted therapies.
Gene Regulatory Network Studies: EMSA is employed to investigate the interactions between transcription factors and regulatory elements in gene regulatory networks. Analyzing the binding of transcription factors to specific promoter or enhancer sequences reveals the structure and function of gene regulatory networks, as well as the role of transcription factors in regulating gene expression.
Functional Studies of Disease-Related Genes: EMSA is used to study the functional regulation of genes associated with diseases. Analyzing the binding of disease-related genes' promoters, enhancers, or regulatory elements to transcription factors provides insights into the regulatory mechanisms of these genes and functional changes associated with diseases.
Creative Proteomics is an international biotechnology company dedicated to research in molecular interactions and other related fields. The electrophoretic mobility shift assay we provided has the characteristics of high quality and efficiency, and the data obtained can be directly used for paper publication. Our one-stop service aims to save customers time and money.
References
The traditional fluorometry method for detecting molecular beacons (MBs) has limitations, including sensitivity issues due to noise from free fluorophores and incomplete quenching. This study explores an alternative approach using gel electrophoresis for MB detection, providing an orthogonal confirmation of binding events and overcoming fluorometry drawbacks.
The study utilizes purified RNA samples obtained from red blood cells (RBCs) of healthy donors. Additionally, synthetic miRNA and DNA oligonucleotide target analogs are employed for testing the MB hybridization detection technique.
MB Hybridization Detection by Gel Electrophoresis:
Blood Draw and RBC Isolation:
RNA Isolation, cDNA Synthesis, and qPCR:
1. Limitations of Fluorometry-Based MB Hybridization Readout:
2. Hybridization of MB to the Target Alters Electrophoretic Properties:
3. Electrophoretic Mobility Can Identify Hybridization of MB to Mutated miRNA Target Analogs:
4. Electrophoretic Mobility Shift Can Identify Endogenous miRNA Species:
Electrophoretic mobility patterns of unbound and bound molecular beacons (MB).
Electrophoretic mobility shift differentiates certain hsa-miR-451a mutated sequences.
Reference